1. Home
  2. GBIO vs VVPR Comparison

GBIO vs VVPR Comparison

Compare GBIO & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • VVPR
  • Stock Information
  • Founded
  • GBIO 2016
  • VVPR 2014
  • Country
  • GBIO United States
  • VVPR United Kingdom
  • Employees
  • GBIO N/A
  • VVPR N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • VVPR Power Generation
  • Sector
  • GBIO Health Care
  • VVPR Utilities
  • Exchange
  • GBIO Nasdaq
  • VVPR Nasdaq
  • Market Cap
  • GBIO 29.2M
  • VVPR 26.9M
  • IPO Year
  • GBIO 2020
  • VVPR 2016
  • Fundamental
  • Price
  • GBIO $0.38
  • VVPR $4.64
  • Analyst Decision
  • GBIO Strong Buy
  • VVPR
  • Analyst Count
  • GBIO 4
  • VVPR 0
  • Target Price
  • GBIO $7.33
  • VVPR N/A
  • AVG Volume (30 Days)
  • GBIO 476.6K
  • VVPR 1.5M
  • Earning Date
  • GBIO 05-07-2025
  • VVPR 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • VVPR N/A
  • EPS Growth
  • GBIO N/A
  • VVPR N/A
  • EPS
  • GBIO N/A
  • VVPR N/A
  • Revenue
  • GBIO $24,556,000.00
  • VVPR $79,000.00
  • Revenue This Year
  • GBIO N/A
  • VVPR N/A
  • Revenue Next Year
  • GBIO N/A
  • VVPR N/A
  • P/E Ratio
  • GBIO N/A
  • VVPR N/A
  • Revenue Growth
  • GBIO 146.47
  • VVPR N/A
  • 52 Week Low
  • GBIO $0.32
  • VVPR $0.62
  • 52 Week High
  • GBIO $3.65
  • VVPR $8.88
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 45.45
  • VVPR 51.81
  • Support Level
  • GBIO $0.37
  • VVPR $4.15
  • Resistance Level
  • GBIO $0.41
  • VVPR $8.88
  • Average True Range (ATR)
  • GBIO 0.03
  • VVPR 1.07
  • MACD
  • GBIO 0.00
  • VVPR -0.03
  • Stochastic Oscillator
  • GBIO 28.93
  • VVPR 10.36

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.

Share on Social Networks: